Interstitial lung diseases and lung cancer

Maria Alvarenga Santos (Lisbon, Portugal), Maria Alvarenga Santos, Susana Clemente, Margarida Felizardo, Cláudia Matos, Sofia Tello Furtado

Source: International Congress 2016 – Clinical aspects of ILD
Session: Clinical aspects of ILD
Session type: Thematic Poster
Number: 813
Disease area: Interstitial lung diseases, Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Maria Alvarenga Santos (Lisbon, Portugal), Maria Alvarenga Santos, Susana Clemente, Margarida Felizardo, Cláudia Matos, Sofia Tello Furtado. Interstitial lung diseases and lung cancer. Eur Respir J 2016; 48: Suppl. 60, 813

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung cancer and interstitial lung disease
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018


Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Surgical treatmment non-small cell lung cancer in the elderly patients
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer
Source: International Congress 2016 – IPF pathogenesis
Year: 2016


Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


A case series of eight patients treated with alectinib including a case of interstitial lung disease
Source: International Congress 2016 – Therapeutic trials in lung cancer
Year: 2016



Interstitial lung diseases
Source: ERS Course 2015
Year: 2015

Interstitial lung diseases
Source: Eur Respir Monogr 2015; 70: 99-115
Year: 2015


Interstitial lung diseases
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Interstitial lung diseases
Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips
Year: 2012

Interstitial lung diseases
Source: Eur Respir Monogr 2014; 65: 79-87
Year: 2014


Interstitial lung diseases
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Interstitial lung diseases
Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Year: 2013


Interstitial lung diseases
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016


Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014